CVT 1.71% $1.15 comvita limited ordinary shares

Ann: GENERAL: CVT: Edison Investment Research releases updated...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 2
    • Release Date: 22/12/14 14:09
    • Summary: GENERAL: CVT: Edison Investment Research releases updated Comvita Report
    • Price Sensitive: No
    • Download Document  2.05KB
    					CVT
    22/12/2014 14:09
    GENERAL
    PRICE SENSITIVE
    REL: 1409 HRS Comvita Limited
    
    GENERAL: CVT: Edison Investment Research releases updated Comvita Report
    
    Edison Investment Research Limited has released an updated Comvita Report
    that is attached to this announcement.
    
    This Edison report has been written using publicly available information.
    Please note that the conclusions and opinions in the report are those of
    Edison Investment Research Limited.
    
    Edison Investment Research Limited will provide ongoing regular analysis
    which we will make available to shareholders.
    
    # Ends #
    
    For further information:
    Comvita CEO, Brett Hewlett, 021 740 160
    Comvita Communications Manager, Julie Chadwick, 021 510 693
    
    Background information
    About Comvita (www.comvita.com)
    Comvita (NZX:CVT) is a global natural health company committed to the
    development of innovative products, backed by ongoing investment in
    scientific research. We are the world leaders in Manuka (leptospermum) honey
    and fresh-picked Olive Leaf Extract, which are at the core of the Comvita
    product range.
    
    We have approximately 50% of honey supply under direct ownership or control,
    with the balance of supply from long term contractual and partnership
    arrangements. Comvita pioneered the development and use of medical grade
    Manuka honey and was the first to receive FDA approval (2007). We partner
    with US wound care company Derma Sciences, Inc. (NASDAQ:DSCI), the global
    licensee for Medihoney specialist wound care products, which are used in
    hospitals and medical centres around the world. Comvita's freshly picked
    Olive Leaf Extract is grown, harvested, extracted and bottled at the world's
    largest specialised olive leaf grove, with over one million olive trees.
    
    Comvita sells into more than 18 countries through a network of our own
    branded retail locations, online (nine country specific e-commerce websites)
    and third-party outlets. We have over 450 staff located in New Zealand,
    Australia, Hong Kong, Japan, Taiwan, South Korea, the United Kingdom and the
    USA.
    End CA:00259271 For:CVT    Type:GENERAL    Time:2014-12-22 14:09:06
    				
 
watchlist Created with Sketch. Add CVT (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.